OZEM Holdings — Roundhill GLP-1 & Weight Loss ETF
All 27 reported holdings of Roundhill GLP-1 & Weight Loss ETF (OZEM) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 16.10% | $8.28M |
| Novo Nordisk A/S | 13.13% | $6.76M |
| Mount Vernon Liquid Assets Portfolio, LLC | 12.14% | $6.24M |
| Pfizer Inc | 7.56% | $3.89M |
| Viking Therapeutics Inc | 5.29% | $2.72M |
| Innovent Biologics Inc | 5.11% | $2.63M |
| Ascletis Pharma Inc | 4.67% | $2.40M |
| Amgen Inc | 3.94% | $2.03M |
| Roche Holding AG | 3.92% | $2.02M |
| AstraZeneca PLC | 3.76% | $1.94M |
| Hanmi Pharm Co Ltd | 3.66% | $1.88M |
| Zealand Pharma A/S | 3.60% | $1.85M |
| Chugai Pharmaceutical Co Ltd | 3.45% | $1.78M |
| Regeneron Pharmaceuticals Inc | 3.33% | $1.71M |
| Fosun Pharma | 3.26% | $1.67M |
| CSPC Pharmaceutical Group Ltd | 2.93% | $1.51M |
| Gubra A/S | 2.42% | $1.24M |
| Structure Therapeutics Inc | 2.38% | $1.22M |
| United Lab | 2.27% | $1.17M |
| MBX Biosciences Inc | 1.99% | $1.02M |
| Gilead Sciences Inc | 1.91% | $981.58K |
| Rhythm Pharmaceuticals Inc | 1.43% | $736.03K |
| Shionogi & Co Ltd | 1.39% | $713.03K |
| Biohaven Ltd | 0.87% | $449.18K |
| First American Government Obli | 0.75% | $388.15K |
| WaVe Life Sciences Ltd | 0.46% | $237.64K |
| Corbus Pharmaceuticals Holding | 0.40% | $207.81K |
OZEM overview: performance, fees, allocation and SEC filings